Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/18/1996 | EP0748631A2 Viral vaccines |
12/18/1996 | EP0748386A1 Production of fibrinogen in transgenic animals |
12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
12/18/1996 | EP0748384A1 Transgenic plants for the control of animal parasites |
12/18/1996 | EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR |
12/18/1996 | EP0748379A1 Modulators of anchoring protein function |
12/18/1996 | EP0748376A1 Rna editing enzyme and methods of use thereof |
12/18/1996 | EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
12/18/1996 | EP0748337A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin |
12/18/1996 | EP0748336A1 Immunosuppressive compounds and method of preparing same |
12/18/1996 | EP0748335A1 Antibiotic stalobacins |
12/18/1996 | EP0748333A1 Antithrombotic agents |
12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
12/18/1996 | EP0618802A4 Synthetic compounds and compositions with enhanced cell binding. |
12/18/1996 | EP0609242B1 New thrombin-inhibiting protein isolated from ticks |
12/18/1996 | EP0554284B1 Peptide-based inhibitors of hiv replication |
12/18/1996 | EP0504371B1 Hiv diagnostic method and reagent |
12/18/1996 | CN1138350A CNTF Family antagonists |
12/18/1996 | CN1138349A Human activated protein C preparation and process for producing the same |
12/18/1996 | CN1138335A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138334A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138295A A novel tumor suppressor gene |
12/17/1996 | US5586226 Control method and device for a unicolor printer |
12/17/1996 | US5585543 Genetic engineering |
12/17/1996 | US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
12/17/1996 | US5585484 Using ethoxylated phenylmaleimido compounds |
12/17/1996 | US5585478 D4 gene and methods of use thereof |
12/17/1996 | US5585476 Diagnosis, therapy |
12/17/1996 | US5585474 DNA encoding protein possessing metastasis-inhibitory activity |
12/17/1996 | US5585467 Cultivating a mycins from fungus strain |
12/17/1996 | US5585466 Crystals of serum albumin for use in genetic engineering and rational drug design |
12/17/1996 | US5585465 Isolated toxin associated with Kawasaki syndrome |
12/17/1996 | US5585464 Recombinant antigen for diagnosing rheumatoid arthritis |
12/17/1996 | US5585463 β3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides |
12/17/1996 | US5585462 Cloning of perilipin proteins |
12/17/1996 | US5585461 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
12/17/1996 | US5585362 Adenovirus vectors for gene therapy |
12/17/1996 | US5585360 Thrombin inhibitors |
12/17/1996 | US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy |
12/17/1996 | US5585354 Suppressant of corneal subepithelial clouding |
12/17/1996 | US5585353 Antibiotic peptides containing D-amino acids |
12/17/1996 | US5585351 T-cadherin adhesion molecule |
12/17/1996 | US5585350 Thrombin-inhibitory protein from ticks |
12/17/1996 | US5585349 Method of treating viral infections |
12/17/1996 | US5585346 Blocking superoxide production in phagocytic cells; antiinflammatory agents; gout; autoimmune disorders; myocardial infarction; respiratory and skin disorders |
12/17/1996 | US5585345 CTP extended form of glycoprotein hormones |
12/17/1996 | US5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereof |
12/17/1996 | US5585271 Yeast agglutination genes and yeast containing them |
12/17/1996 | US5585270 Polynucleotides encoding connective tissue growth factor |
12/17/1996 | US5585269 Nucleotide sequence which encodes a receptor having tyrosine kinase activity |
12/17/1996 | US5585268 Purified isolated dna sequence encoding specified amino acid sequence or fragment encoding polypeptide reactive with antiserum to specified plasmodium falciparum band |
12/17/1996 | US5585267 Hemidesmosome formation-inducing protein coated on appliance |
12/17/1996 | US5585264 Useful in vaccines to prevent disease in cattle |
12/17/1996 | US5585263 Nucleotide sequence effecting the rev-dependent expression of structural proteins, gag, pol and env, in the absence of rev expression; hiv vaccine; |
12/17/1996 | US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus |
12/17/1996 | US5585259 Ecotin as a factor Xa, XIa, and XIIa inhibitor |
12/17/1996 | US5585258 Hepatitis C virus protease |
12/17/1996 | US5585254 Autonomous parvovirus gene delivery vehicles and expression vectors |
12/17/1996 | US5585250 Hiv-1 vaccine; variations and modifications of the v3 loop including additional glycosylation signals |
12/17/1996 | US5585245 Protein complex |
12/17/1996 | US5585244 Contacting with antibody that binds to both receptor and a peptide comprising a segment of a hinge region of the receptor; complex formation |
12/17/1996 | US5585239 Herpes simplex virus drug screen |
12/17/1996 | US5585237 Stable genetically engineered cells containing transfected dna sequences which code for viral transcription promoters and activators |
12/17/1996 | US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova |
12/17/1996 | US5585233 Mutant; gebnetic engineering |
12/17/1996 | US5585102 Flagella-less borrelia |
12/17/1996 | US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
12/17/1996 | US5585089 Humanized immunoglobulins |
12/17/1996 | US5585087 Assay for identifying extracellular signaling proteins |
12/17/1996 | US5585007 Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
12/17/1996 | CA2178975A1 Phages resistant streptococcus |
12/17/1996 | CA2068190C Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase |
12/17/1996 | CA2006684C Monoclonal antibody against protein c |
12/17/1996 | CA1338800C Hepatitis delta and diagnostics and vaccines |
12/16/1996 | WO1996039508A1 Fibroblast growth factor 13 |
12/16/1996 | CA2220988A1 Fibroblast growth factor 13 |
12/16/1996 | CA2178894A1 Parathyroid hormone derivatives and their use |
12/12/1996 | WO1996039630A1 Detection of htlv antibodies utilizing recombinant proteins |
12/12/1996 | WO1996039628A1 GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS |
12/12/1996 | WO1996039542A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
12/12/1996 | WO1996039541A1 Colon specific gene and protein |
12/12/1996 | WO1996039540A1 Novel gene-up regulated in regenerating liver |
12/12/1996 | WO1996039531A1 Delivery of nucleotides into organisms by electroporation |
12/12/1996 | WO1996039529A1 Compositions for expression of proteins in host cells using a preprocollagen signal sequence |
12/12/1996 | WO1996039525A1 Cloning and expression of thermostable muts genes and proteins and uses therefor |
12/12/1996 | WO1996039524A1 Methods for enhancement of protective immune responses |
12/12/1996 | WO1996039523A2 Bacterial production of hydrophobic polypeptides |
12/12/1996 | WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | WO1996039521A1 Human chemokine beta-13 |
12/12/1996 | WO1996039520A1 Human chemokine beta-12 |
12/12/1996 | WO1996039519A1 Kunitz type plasma kallikrein inhibitors |
12/12/1996 | WO1996039517A1 The erf genetic locus and its products |
12/12/1996 | WO1996039516A2 Targets for breast cancer diagnosis and treatment |
12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |
12/12/1996 | WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
12/12/1996 | WO1996039513A2 Ebnerin cloning of a secreted von ebner's gland protein |
12/12/1996 | WO1996039512A2 A cell line for the rapid expression of functional calcium channels |
12/12/1996 | WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
12/12/1996 | WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells |
12/12/1996 | WO1996039509A1 Fibroblast growth factor 15 |